Clinical resemblance of widespread bullous fixed drug eruption to Stevens-Johnson syndrome or toxic epidermal necrolysis: Report of two cases

被引:0
作者
Lin, TK [1 ]
Hsu, MML [1 ]
Lee, JYY [1 ]
机构
[1] Natl Cheng Kung Univ Hosp, Dept Dermatol, Tainan, Taiwan
关键词
widespread bullous fixed drug eruption; toxic epidermal necrolysis; Stevens-Johnson syndrome; diclofenac; naproxen; ketoprofen;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Widespread bullous fixed drug eruption (FDE) is the most severe form of FDE and may be mistaken clinically for Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN). We report two cases of generalized bullous drug eruption with extensive epidermal necrosis and detachment mimicking SJS/TEN overlap and TEN, respectively. The first patient, a 78-year-old man, developed SJS/TEN-like eruption with widespread dusky red patches and denuded areas shortly after taking multiple nonsteroidal antiinflammatory drugs (NSAIDs). Histopathology showed vacuolar interface dermatitis with numerous necrotic keratinocytes and a superficial and deep perivascular infiltrate containing lymphocytes, eosinophils, neutrophils and melanophages. These findings are consistent with FDE. The second patient, a 61-year-old woman, had three episodes of near-total body epidermal detachment shortly after taking NSAIDs. TEN was diagnosed clinically in all three episodes without pathologic confirmation. FDE was suspected due to lack of involvement of two mucosal sites and uneventful recovery. These cases highlight the importance of considering severe bullous FDE in the differential diagnosis of SJS and TEN, and the necessity of skin biopsy in such cases.
引用
收藏
页码:572 / 576
页数:5
相关论文
共 50 条
  • [21] Clinical characteristics and treatment outcome of Stevens-Johnson syndrome and toxic epidermal necrolysis
    Chantaphakul, Hiroshi
    Sanon, Thanomsak
    Klaewsongkram, Jettanong
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 10 (02) : 519 - 524
  • [22] Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    Lerch, Marianne
    Mainetti, Carlo
    Beretta-Piccoli, Benedetta Terziroli
    Harr, Thomas
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2018, 54 (01) : 147 - 176
  • [23] Managing the ADR of Stevens-Johnson syndrome/toxic epidermal necrolysis
    Lian, Bertrand Sheng-Yang
    Lee, Haur Yueh
    EXPERT OPINION ON DRUG SAFETY, 2022, 21 (08) : 1039 - 1046
  • [24] Wound Management in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    Jose A. Jaller
    Beth N. McLellan
    Yevgeniy Balagula
    Current Dermatology Reports, 2020, 9 : 58 - 72
  • [25] Otologic complications of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    Hotaling, Jeffrey M.
    Hotaling, Andrew J.
    INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2014, 78 (08) : 1408 - 1409
  • [26] An update on Stevens-Johnson syndrome and toxic epidermal necrolysis in children
    Koh, Mark Jean-Aan
    Tay, Yong-Kwang
    CURRENT OPINION IN PEDIATRICS, 2009, 21 (04) : 505 - 510
  • [27] Stevens-Johnson syndrome/toxic epidermal necrolysis associated with zonisamide
    Vivar, Karina L.
    Mancl, Kimberly
    Seminario-Vidal, Lucia
    CLINICAL CASE REPORTS, 2018, 6 (02): : 258 - 261
  • [28] Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Guide for Nurses
    Hanson, Leah M.
    Bettencourt, Amanda P.
    AACN ADVANCED CRITICAL CARE, 2020, 31 (03) : 281 - 295
  • [29] The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis
    Mockenhaupt, Maja
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2011, 7 (06) : 803 - 815
  • [30] Update on pathobiology in Stevens-Johnson syndrome and toxic epidermal necrolysis
    Su, Shih-Chi
    Chung, Wen-Hung
    DERMATOLOGICA SINICA, 2013, 31 (04) : 175 - 180